SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 5, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $1.3M total
Actionable Insight • Neutral

The insider sales are mechanically tied to option exercises and are trivial relative to Teva's $40.5B market cap. No bearish signal. Monitor the upcoming H2 ramp implied by maintained non-GAAP EPS guidance of $1.91-$2.11 and the Fitch upgrade to BBB- for the real earnings story.

DirectionNeutral
Confidencehigh
Horizonimmediate

Drugs in focus

TEVA drug pipeline →

AUSTEDO

● Neutral Named in this insider cluster
Impact
Phase
Approved
Time to market
Already on the market — first approved April 2017; Austedo XR approved February 2023
Next catalyst
None dated

What to watchAustedo is a mature, approved revenue driver for Teva, commercial execution and growth trajectory matter more than any single catalyst. Watch Teva's quarterly innovative brand revenue growth rate (43% LC YoY in H1 2026) and any label-expansion trial updates for downward drift potential, as the binary approval catalysts are years past.

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$34.81
T+0 close · Aug 5, 2026 · via day close
Latest settled
+20.91%
T+60 · $42.09
Vs SPY
+22.58%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 6 $34.81entry
  2. T+1 · 3mo ago +1.58%α +0.97% · $35.36
  3. T+5 · 3mo ago +4.70%α +3.49% · $36.45
  4. T+20 · 3mo ago +5.16%α +4.56% · $36.61
  5. T+60 · 18d ago +20.91%α +22.58% · $42.09
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Teva insiders (Hughes and Jover) sold a combined $1.34M in open-market shares on August 3, 2026, at ~$34.88/share, following the exercise of stock options at $0 exercise price. The sales occurred just 8 days after Teva's Q2 2026 earnings miss (revenue -1% YoY, GAAP loss of -$0.49/share), and represent 0.003% of Teva's $40.5B market cap, a trivial amount. The cluster is entirely option-exercise-and-sell transactions, a routine pattern for tax/cash purposes, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$1.3M
Insiders
2

Key Facts

  • Two insiders sold $1.34M total (0.003% of $40.5B market cap)
  • All sales were same-day option exercises at $0 exercise price, routine cash-out pattern
  • Sales occurred 8 days after Q2 earnings miss (revenue $4.14B, -1% YoY; GAAP EPS -$0.49)
  • No open-market purchases in the cluster, only derivative exercises followed by sales

Financial Impact

$1.34M in insider sales, representing 0.003% of market cap, immaterial

insider holdingsdilution

Risk Factors

  • Q2 revenue decline of -1% YoY and GAAP loss of -$0.49/share
  • $726M Emalex acquisition charge weighing on reported earnings
  • Insider cluster may be misread as bearish by less sophisticated traders

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-TEVA-1786004921253

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $44.50 +3.10% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $44.50 0.00% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $44.50 0.00% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $44.50 +1.95% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $44.50 +2.91% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $44.50 +4.95% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $44.50 +4.95% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $44.50 +3.56% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $44.50 +3.56% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $44.50 +4.44% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens Wed (12h 12m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 6, 2026